| Characteristic |
(n = 43) |
| Age – Median years (range) |
38 (22-63) |
| Sex – Male/Female |
23/20 |
| Underlying disease – n (%) |
|
| Malignant disease |
|
| Acute lymphocytic leukemia (ALL) |
3 (6.9) |
| Acute myelogenous leukemia (AML) |
8 (18.6) |
| Chronic myelogenous leukemia (CML) |
18 (41.9) |
| Multiple Myeloma (MM) |
6 (14) |
| Non-Hodgkin Lymphoma (NHL) |
2 (4.65) |
| Severe aplastic anaemia (SAA) |
3 (6.9) |
| Others |
3 (6.9) |
| Pretransplant CMV serostatus – n (%) |
|
| R+/D+ |
39 (90.7) |
| R-/D+ |
4 (9.3) |
| Stem cell source |
|
| Bone marrow |
17 (39.5) |
| Peripheral blood |
26 (60.5) |
